{"id":"https://openalex.org/W1972156735","doi":"https://doi.org/10.1097/00004850-199300830-00002","title":"Fluoxetine versus amitriptyline in the treatment of major depression: a multicenter trial","display_name":"Fluoxetine versus amitriptyline in the treatment of major depression: a multicenter trial","alternate_titles":[],"publication_year":1993,"publication_date":"1993-01-01","ids":{"openalex":"https://openalex.org/W1972156735","doi":"https://doi.org/10.1097/00004850-199300830-00002","mag":"1972156735","pmid":"https://pubmed.ncbi.nlm.nih.gov/8263311"},"language":"en","primary_location":{"id":"doi:10.1097/00004850-199300830-00002","doi":"https://doi.org/10.1097/00004850-199300830-00002","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-199300830-00002","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1972156735"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016744088","display_name":"Charles M. Beasley","orcid":"https://orcid.org/0000-0001-8743-7691","observed_orcids":["https://orcid.org/0000-0001-8743-7691"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. M. Beasley","raw_affiliation_strings":["Psychopharmacology Division, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285","Psychopharmacology Division, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center 2128, Indianapolis, IN 46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychopharmacology Division, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Psychopharmacology Division, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center 2128, Indianapolis, IN 46285, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024791837","display_name":"Mary E. Sayler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. E. Sayler","raw_affiliation_strings":["Psychopharmacology Division, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center 2128, Indianapolis, IN 46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychopharmacology Division, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center 2128, Indianapolis, IN 46285, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111623572","display_name":"Janet H. Potvin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. H. Potvin","raw_affiliation_strings":["Psychopharmacology Division, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center 2128, Indianapolis, IN 46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychopharmacology Division, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center 2128, Indianapolis, IN 46285, USA","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":null,"apc_paid":null,"fwci":1.5448,"has_fulltext":false,"cited_by_count":33,"citation_normalized_percentile":{"value":0.81483016,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":92},"biblio":{"volume":"8","issue":"3","first_page":"143","last_page":"150"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10272","display_name":"Mental Health Treatment and Access","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.9850000143051147},{"id":"https://openalex.org/keywords/amitriptyline","display_name":"amitriptyline","score":1.0},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9959999918937683},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.8339999914169312},{"id":"https://openalex.org/keywords/antidepressant-safety","display_name":"antidepressant safety","score":0.7369999885559082},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.8270000219345093},{"id":"https://openalex.org/keywords/tricyclic-antidepressants","display_name":"tricyclic antidepressants","score":1.0},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5149999856948853},{"id":"https://openalex.org/keywords/nausea","display_name":"nausea","score":0.6470000147819519},{"id":"https://openalex.org/keywords/insomnia","display_name":"insomnia","score":0.9110000133514404},{"id":"https://openalex.org/keywords/anticholinergic-effects","display_name":"anticholinergic effects","score":0.9409999847412109},{"id":"https://openalex.org/keywords/orthostatic-hypotension","display_name":"orthostatic hypotension","score":0.8519999980926514},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.8840000033378601},{"id":"https://openalex.org/keywords/treatment-response-and-remission","display_name":"treatment response and remission","score":0.6470000147819519},{"id":"https://openalex.org/keywords/outpatients","display_name":"outpatients","score":0.7269999980926514}],"concepts":[{"id":"https://openalex.org/C2780216858","wikidata":"https://www.wikidata.org/wiki/Q58397","display_name":"Amitriptyline","level":2,"score":0.962822675704956},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.8769845962524414},{"id":"https://openalex.org/C2778689640","wikidata":"https://www.wikidata.org/wiki/Q113259","display_name":"Anticholinergic","level":2,"score":0.6787824630737305},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5504546761512756},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.47649306058883667},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4761914312839508},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46588319540023804},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.4599657654762268},{"id":"https://openalex.org/C2781081902","wikidata":"https://www.wikidata.org/wiki/Q3539074","display_name":"Tricyclic","level":2,"score":0.4499191641807556},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.43788477778434753},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4274079203605652},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.4169948697090149},{"id":"https://openalex.org/C2777393122","wikidata":"https://www.wikidata.org/wiki/Q416417","display_name":"Akathisia","level":4,"score":0.4148629903793335},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2431577444076538},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.23964813351631165},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.2338595986366272},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.07804134488105774},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.06857320666313171},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000639","descriptor_name":"Amitriptyline","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000639","descriptor_name":"Amitriptyline","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004850-199300830-00002","doi":"https://doi.org/10.1097/00004850-199300830-00002","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-199300830-00002","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:8263311","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8263311","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International clinical psychopharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2419520937","https://openalex.org/W2377633021","https://openalex.org/W64060380","https://openalex.org/W2032838626","https://openalex.org/W2043512713","https://openalex.org/W2389495525","https://openalex.org/W1998215154","https://openalex.org/W2369923817","https://openalex.org/W2358731835","https://openalex.org/W1814905825"],"abstract_inverted_index":{"Fluoxetine,":[0],"a":[1,7,13,222],"serotonin":[2],"uptake":[3],"inhibitor,":[4],"and":[5,23,38,52,70,99,104,116,123,133,168,181,184,209],"amitriptyline,":[6],"tricyclic":[8],"antidepressant,":[9],"were":[10,66,97,114,129,137,153,170,187,202,211],"compared":[11],"in":[12,19,62,85,204],"5-week,":[14],"multicenter,":[15],"double-blind,":[16],"randomized":[17],"trial":[18],"136":[20],"out-patient":[21],"men":[22],"women,":[24],"aged":[25],"21-70":[26],"years,":[27],"with":[28,36,131,139,155,172,189,216],"major":[29,217],"depressive":[30,218],"disorder.":[31,219],"Overall":[32],"efficacy":[33],"was":[34],"comparable":[35,130],"fluoxetine":[37,132,140,158,173,208],"amitriptyline":[39,142,156,190,210],"[Hamilton":[40],"21-Item":[41],"Rating":[42],"Scale":[43],"for":[44,89,126,150,214],"Depression":[45],"(HAM-D21),":[46],"Raskin,":[47],"Covi,":[48],"Clinical":[49],"Global":[50,55],"Impressions-Severity":[51],"-Improvement,":[53],"Patient's":[54],"Impressions].":[56],"Mean":[57],"+/-":[58,68,72],"standard":[59],"deviation":[60],"decreases":[61],"HAM-D21":[63,86],"total":[64,87,108],"score":[65,109],"12.9":[67],"9.9":[69],"11.6":[71],"10.3":[73],"(p":[74,101,118,174,191],"=":[75,82,94,102,112,119,147,163,177,194],"0.423),":[76],"respectively.":[77,121],"Response":[78,122],"rates":[79,106,125],"(>":[80],"or":[81,93,111,176,193],"50%":[83],"decrease":[84],"score)":[88],"patients":[90,128],"treated":[91],">":[92],"4":[95],"weeks":[96],"46.7%":[98],"66.0%":[100],"0.039)":[103],"remission":[105,124],"(HAM-D21":[107],"<":[110,175,192],"7)":[113],"18.3%":[115],"28.3%":[117],"0.209),":[120],"all":[127],"amitriptyline.":[134,228],"Study":[135],"completions":[136],"higher":[138,154],"than":[141,157,227],"(87.7%":[143],"vs":[144,160],"66.2%;":[145],"p":[146,162],"0.003).":[148],"Discontinuations":[149],"adverse":[151],"events":[152,183],"(22.5%":[159],"6.2%;":[161],"0.007).":[164],"More":[165],"treatment-emergent":[166],"nausea":[167],"insomnia":[169],"reported":[171,188],"0.05);":[178],"more":[179,223],"anticholinergic":[180],"orthostatic":[182],"weight":[185],"gain":[186],"0.05).":[195],"Statistically,":[196],"but":[197],"not":[198],"clinically,":[199],"significant":[200],"changes":[201],"observed":[203],"vital":[205],"signs.":[206],"Both":[207],"effective":[212],"treatments":[213],"out-patients":[215],"Fluoxetine":[220],"had":[221],"favorable":[224],"safety":[225],"profile":[226]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1972156735","counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
